Key facts
- Notable investors include Suzhou Oriza Holdings Corporation, Suzhou Guofa Venture Capital, Insight Capital (Taicang), Taicang Industrial Fund Management, Zhuoruan Medical Technology.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for Zhuoruan Medical Technology
- ·The full record, as it builds
Funding rounds
No funding rounds for Zhuoruan Medical Technology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Zhuoruan Medical Technology
Manufacturer of biomaterial-based medical devices designed to support surgical tissue reconstruction and regenerative tissue repair. The company offers basement membrane-derived biomaterials, extracellular matrix production capabilities, and implantable medical products across multiple surgical fields, enabling healthcare providers and medical institutions to improve clinical outcomes with advanced tissue repair technologies.
- Sector
- Healthcare
- HQ
- Suzhou, China
- Founded
- 2016
- Website
- exmed.cn/
- Ownership
- Privately Held (backing)
Zhuoruan Medical Technology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Zhuoruan Medical Technology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Zhuoruan Medical Technology in its N-PORT filings yet. We sweep new filings monthly.